SOFTMEDX (00648) released its annual performance, with a net profit of HK$6.95 million, a decrease of 97.87% year-on-year.

date
23:07 27/03/2026
avatar
GMT Eight
Jingjukang Therapy (00648) announced its performance for the end of 2025. The group achieved revenue of HK$68.243 million during the period, an increase of 24.9% year-on-year; net profit for the year was HK$6.95 million, a decrease of 97.87% year-on-year; and earnings per share were HK$0.012.
SOFTMEDX (00648) announced its performance at the end of 2025, with a profit of HK$68.243 million for the period, an increase of 24.9% year-on-year; a net profit of HK$6.95 million for the year, a decrease of 97.87% year-on-year; basic earnings per share of HK$0.012.